A shipment of 50 million face masks bought for the NHS as part of a £252 million contract will not be given to health workers because they’re the wrong kind.
The manufacturing process for this new formulation, along with its antiviral, antibacterial and antiparasitic properties has now been submitted as a patent application by P2F to protect its intellectual property